Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Occipital Nerve Blocks for Pediatric Migraine
NCT03526874Phase 3Completed
- Sponsor
- Children's Hospital of Philadelphia
- Start
- Apr 2019
- Primary completion
- Mar 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of lidocaine 10% oropharyngeal spray in migraine, sponsored by Children's Hospital of Philadelphia. Started Apr 2019; status: completed.
02
Drugs
lidocaine 10% oropharyngeal spray
03
Conditions
migraine
Beyond the preview
Go deeper on NCT03526874.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03526874.